Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
47.42
-1.03 (-2.13%)
Official Closing Price
Updated: 7:00 PM EST, Feb 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
12,285,852
Open
47.69
Bid (Size)
47.44 (100)
Ask (Size)
47.47 (200)
Prev. Close
48.45
Today's Range
47.03 - 47.75
52wk Range
43.08 - 93.80
Shares Outstanding
N/A
Dividend Yield
2.46%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
2 Unstoppable Dividend Stocks to Buy Right Now for Less Than $200
↗
Today 10:02 EST
These two healthcare stocks are likely headed higher from their current prices.
Via
The Motley Fool
Hims & Hers in Free Fall: Why Analysts See Nearly 150% Upside
↗
February 21, 2026
Via
MarketBeat
Performance
YTD
-9.5%
-9.5%
1 Month
-23.8%
-23.8%
3 Month
+5.4%
+5.4%
6 Month
-15.8%
-15.8%
1 Year
-46.2%
-46.2%
More News
Read More
Novo Nordisk Stock Investors Just Got Great News From Eli Lilly
↗
February 20, 2026
Via
The Motley Fool
Is Pfizer Stock the Only Big Pharma Name I'd Buy and Hold Through Any Market Crash?
↗
February 20, 2026
Via
The Motley Fool
Topics
Intellectual Property
Novo Looks To Ireland To Scale Production Of Wegovy Pill: Report
↗
February 12, 2026
Via
Stocktwits
2 Innovative Biotech Stocks That May Climb 58% and 200%, According to Wall Street
↗
February 19, 2026
Via
The Motley Fool
Warning: This Skyrocketing Stock Has a Hidden Risk
↗
February 19, 2026
Via
The Motley Fool
Topics
Intellectual Property
Overlooked and Undervalued: Why Novo Nordisk Stock Deserves Attention
↗
February 19, 2026
Via
The Motley Fool
Hims & Hers HUGE Acquisition News!
↗
February 19, 2026
Via
The Motley Fool
Forget Ozempic: This Obesity‑Drug Giant Is Grabbing the Biggest Slice of the GLP‑1 Gold Rush
↗
February 19, 2026
Via
The Motley Fool
The Trillion-Dollar Pharmaceutical Giant: Eli Lilly Makes History as Weight-Loss Revolution Drives Unprecedented Growth
February 17, 2026
Via
MarketMinute
Topics
Earnings
Economy
NVO Stock Generates Retail Buzz After European Commission Approves 7.2 MG Once-Weekly Dose Of Wegovy Injection
↗
February 17, 2026
Via
Stocktwits
Topics
Lawsuit
2026 Could Be a Big Year for Viking Therapeutics. Time to Buy?
↗
February 17, 2026
Via
The Motley Fool
Novo Nordisk's New Diabetes Drug Outshines Ozempic: Is The Stock a Buy?
↗
February 16, 2026
Via
The Motley Fool
Got $500? 2 Pharma Stocks to Buy and Hold Forever.
↗
February 14, 2026
Via
The Motley Fool
Novo Nordisk To Meet Wegovy Pill Demand In US Before Expanding To Avoid Supply Shortage, Says CEO Doustdar
↗
February 13, 2026
Via
Stocktwits
Topics
Lawsuit
Meet the 6.3% Yield Dividend Stock That Could Soar in 2026
↗
February 13, 2026
Via
The Motley Fool
Topics
Intellectual Property
VKTX Stock Has Nearly 300% Wall Street Upside — Is Viking’s Oral Obesity Pill The Next Novo Nordisk-Style Breakout?
↗
February 12, 2026
Via
Stocktwits
Eli Lilly vs Novo Nordisk in the Weight Loss Drug Market: Here's What Investors Need to Know.
↗
February 12, 2026
Via
The Motley Fool
Novo Nordisk CEO Sees Opportunity For 15 Million New Patients As Medicare Covers Obesity Drugs
↗
February 12, 2026
Via
Benzinga
Novo Nordisk Reportedly Eyes Launching Wegovy In Vials To Compete With Rival Eli Lilly
↗
February 11, 2026
Via
Stocktwits
Topics
Intellectual Property
The Greenland Gambit: Inside the Transatlantic Tariff Shock and the Future of Arctic Sovereignty
February 11, 2026
Via
MarketMinute
Topics
Bonds
Economy
Government
Disney Has Its Next CEO
↗
February 11, 2026
Via
The Motley Fool
Healthcare Stocks Are Sinking. Here Are 2 to Buy on the Dip.
↗
February 11, 2026
Via
The Motley Fool
Biotech Beat Nvidia in 2025. Can It Do It Again?
↗
February 11, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 47.42
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 02/20/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.